CHEMOENDOCRINE NEUROPATHY AS A COMPLICATION OF ANTICANCER THERAPY. A REVIEW OF THE LITERATURE

Complications combined with antineoblastic chemotherapeutic therapy are an important and challenging problem, which has an extremely negative effect on patient's status and state of disease. Also these complications demand to change therapy tactics, that directly affects the effectiveness of the therapy. Therefore, early diagnosis and prevention of chemo-induced complications significantly improves the prognosis of the disease. In neurological practice, the most common complication of oncological diseases therapy is chemoinduced polyneuropathy, that is the subject of the article.